Literature DB >> 21047574

Hypercoagulable states.

Julia A M Anderson1, Jeffrey I Weitz.   

Abstract

Hypercoagulable states can be inherited or acquired. Inherited hypercoagulable states can be caused by a loss of function of natural anticoagulant pathways or a gain of function in procoagulant pathways. Acquired hypercoagulable risk factors include a prior history of thrombosis, obesity, pregnancy, cancer and its treatment, antiphospholipid antibody syndrome, heparin-induced thrombocytopenia, and myeloproliferative disorders. Inherited hypercoagulable states combine with acquired risk factors to establish the intrinsic risk of venous thromboembolism for each individual. Venous thromboembolism occurs when the risk exceeds a critical threshold. Often a triggering factor, such as surgery, pregnancy, or estrogen therapy, is required to increase the risk above this critical threshold.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047574     DOI: 10.1016/j.ccm.2010.07.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  15 in total

Review 1.  The value of postoperative anticoagulants to improve flap survival in the free radial forearm flap: a systematic review and retrospective multicentre analysis.

Authors:  J E Swartz; M C J Aarts; K M A Swart; J J Disa; M Gerressen; Y-R Kuo; M K Wax; W Grolman; W W Braunius
Journal:  Clin Otolaryngol       Date:  2015-12       Impact factor: 2.597

2.  Interaction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertension.

Authors:  Joshua P Fessel; Xinping Chen; Andrea Frump; Santhi Gladson; Tom Blackwell; Christie Kang; Jennifer Johnson; James E Loyd; Anna Hemnes; Eric Austin; James West
Journal:  Pulm Circ       Date:  2013-12-02       Impact factor: 3.017

3.  Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer.

Authors:  Robert A Bell; Haley McDermott; Tonya L Fancher; Michael J Green; Frank C Day; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2014-12-02       Impact factor: 5.128

4.  A large and massive abdominal venous thrombosis associated with the presence of a big axillary mass, lupus-like syndrome and antiphospholipid antibodies.

Authors:  Elia Ascer; Liv Goldstein Ascer; Magnus Gidlund
Journal:  BMJ Case Rep       Date:  2011-06-29

Review 5.  Modeling thrombin generation: plasma composition based approach.

Authors:  Kathleen E Brummel-Ziedins; Stephen J Everse; Kenneth G Mann; Thomas Orfeo
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

6.  HIV-Associated Venous Thromboembolism.

Authors:  Michele Bibas; Gianluigi Biava; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

7.  Cerebral venous thrombosis in a breast cancer patient taking tamoxifen: Report of a case.

Authors:  Yoon Kim; Ok Joon Kim; Jinkwon Kim
Journal:  Int J Surg Case Rep       Date:  2014-11-28

8.  Experimental Validation of Methods for Prophylaxis against Deep Venous Thrombosis: A Review and Proposal.

Authors:  Paul S Agutter; P Colm Malone; Ian A Silver
Journal:  Thrombosis       Date:  2012-04-10

Review 9.  Gender, sex hormones and pulmonary hypertension.

Authors:  Eric D Austin; Tim Lahm; James West; Stevan P Tofovic; Anne Katrine Johansen; Margaret R Maclean; Abdallah Alzoubi; Masahiko Oka
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

10.  Treatment with Huisheng oral solution inhibits the development of pulmonary thromboembolism and metastasis in mice with Lewis lung carcinoma.

Authors:  Wei Wang; Hong Wang; Chun-Mei Wang; Si Gou; Zhong-Hua Chen; Jie Guo
Journal:  Oncol Lett       Date:  2013-11-06       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.